Human Genome Epidemiology Literature Finder
|
Records 1 - 28 (of 28 Records) |
| Query Trace: Cholangiocarcinoma and ARID1A[original query] |
|---|
| Mutation profiling in cholangiocarcinoma: prognostic and therapeutic implications. PloS one 2014 9 (12): e115383. Churi Chaitanya R, Shroff Rachna, Wang Ying, Rashid Asif, Kang HyunSeon C, Weatherly Jacqueline, Zuo Mingxin, Zinner Ralph, Hong David, Meric-Bernstam Funda, Janku Filip, Crane Christopher H, Mishra Lopa, Vauthey Jean-Nicholas, Wolff Robert A, Mills Gordon, Javle Mili |
| Loss of ARID1A Expression Presents a Novel Pathway of Carcinogenesis in Biliary Carcinomas. American journal of clinical pathology 2016 Jun 145 (6): 815-25. Sasaki Motoko, Nitta Takeo, Sato Yasunori, Nakanuma Yasu |
| Cholangiocarcinoma Heterogeneity Revealed by Multigene Mutational Profiling: Clinical and Prognostic Relevance in Surgically Resected Patients. Annals of surgical oncology 2015 Dec . Ruzzenente Andrea, Fassan Matteo, Conci Simone, Simbolo Michele, Lawlor Rita T, Pedrazzani Corrado, Capelli Paola, D'Onofrio Mirko, Iacono Calogero, Scarpa Aldo, Guglielmi Alfre |
| Cholangiolocellular Carcinoma With "Ductal Plate Malformation" Pattern May Be Characterized by ARID1A Genetic Alterations. The American journal of surgical pathology 2018 12 43 (3): 352-360. Sasaki Motoko, Sato Yasunori, Nakanuma Yasu |
| Therapeutic relevance of targeted sequencing in management of patients with advanced biliary tract cancer: DNA damage repair gene mutations as a predictive biomarker. European journal of cancer (Oxford, England : 1990) 2019 Aug 120 31-39. Chae Heejung, Kim Deokhoon, Yoo Changhoon, Kim Kyu-Pyo, Jeong Jae Ho, Chang Heung-Moon, Lee Sang Soo, Park Do Hyun, Song Tae Jun, Hwang Shin, Kim Ki-Hun, Song Gi-Won, Ahn Chul Soo, Lee Jae Hoon, Hwang Dae Wook, Kim Song Cheol, Jang Se Jin, Hong Seung-Mo, Kim Tae Won, Ryoo Baek-Ye |
| Patterns of gene mutations in bile duct cancers: is it time to overcome the anatomical classification? HPB : the official journal of the International Hepato Pancreato Biliary Association 2019 May . Bagante Fabio, Ruzzenente Andrea, Conci Simone, Rusev Borislav C, Simbolo Michele, Campagnaro Tommaso, Pawlik Timothy M, Luchini Claudio, Iacono Calogero, Scarpa Aldo, Guglielmi Alfre |
| Somatic Mutations from Whole Exome Sequencing Analysis of the Patients with Biliary Tract Cancer. Genomics & informatics 2019 1 16 (4): e35. Yoon Kyong-Ah, Woo Sang Myung, Kim Yun-Hee, Kong Sun-Young, Han Sung-Sik, Park Sang-Jae, Lee Woo J |
| Characteristics of genomic alterations in Chinese cholangiocarcinoma patients. Japanese journal of clinical oncology 2020 Jun . Jiang Guoping, Zhang Wu, Wang Ting, Ding Songming, Shi Xiaoliang, Zhang Shuirong, Shi Weiwei, Liu Angen, Zheng Shus |
| Multigene mutational profiling of biliary tract cancer is related to the pattern of recurrence in surgically resected patients. Updates in surgery 2020 2 72 (1): 119-128. Conci Simone, Ruzzenente Andrea, Simbolo Michele, Bagante Fabio, Rusev Borislav, Isa Giulia, Lawlor Rita T, Pedrazzani Corrado, Iacono Calogero, Guglielmi Alfredo, Scarpa Al |
| ARID1A alterations and their clinical significance in cholangiocarcinoma. PeerJ 2020 12 8 e10464. Namjan Achira, Techasen Anchalee, Loilome Watcharin, Sa-Ngaimwibool Prakasit, Jusakul Apin |
| Diagnostic and Prognostic Value of Circulating Cell-Free DNA for Cholangiocarcinoma. Diagnostics (Basel, Switzerland) 2021 6 11 (6): . Wintachai Preawwalee, Lim Jing Quan, Techasen Anchalee, Lert-Itthiporn Worachart, Kongpetch Sarinya, Loilome Watcharin, Chindaprasirt Jarin, Titapun Attapol, Namwat Nisana, Khuntikeo Narong, Jusakul Apin |
| Mutational spectrum and precision oncology for biliary tract carcinoma. Theranostics 2021 3 11 (10): 4585-4598. Lin Jianzhen, Cao Yinghao, Yang Xu, Li Guangyu, Shi Yang, Wang Dongxu, Long Junyu, Song Yang, Mao Jinzhu, Xie Fucun, Bai Yi, Zhang Lei, Yang Xiaobo, Wan Xueshuai, Wang Anqiang, Guan Mei, Zhao Lin, Hu Ke, Pan Jie, Huo Li, Lu Xin, Mao Yilei, Sang Xinting, Zhang Henghui, Wang Kai, Wang Xiaoyue, Zhao Hait |
| Clinically significant genomic alterations in the Chinese and Western patients with intrahepatic cholangiocarcinoma. BMC cancer 2021 Feb 21 (1): 152. Xu Shifeng, Guo Yuan, Zeng Yanwu, Song Zhijian, Zhu Xiaodan, Fan Ning, Zhang Zhilei, Ren Guibing, Zang Yunjin, Rao W |
| Benchmarking Outcomes after Ablative Radiotherapy for Molecularly Characterized Intrahepatic Cholangiocarcinoma. Journal of personalized medicine 2021 12 11 (12): . De Brian, Abu-Gheida Ibrahim, Patel Aashini, Ng Sylvia S W, Zaid Mohamed, Thunshelle Connor P, Elganainy Dalia, Corrigan Kelsey L, Rooney Michael K, Javle Milind, Raghav Kanwal, Lee Sunyoung S, Vauthey Jean-Nicolas, Tzeng Ching-Wei D, Tran Cao Hop S, Ludmir Ethan B, Minsky Bruce D, Smith Grace L, Holliday Emma B, Taniguchi Cullen M, Koong Albert C, Das Prajnan, Koay Eugene |
| Comprehensive analysis of genomic alterations of Chinese hilar cholangiocarcinoma patients. International journal of clinical oncology 2021 Jan . Feng Feiling, Wu Xiaobing, Shi Xiaoliang, Gao Qingxiang, Wu Yue, Yu Yong, Cheng Qingbao, Li Bin, Yi Bin, Liu Chen, Hao Qing, Zhang Lin, Gao Chunfang, Jiang Xiaoqi |
| Prevalence of ARID1A Mutations in Cell-Free Circulating Tumor DNA in a Cohort of 71,301 Patients and Association with Driver Co-Alterations. Cancers 2022 9 14 (17): . Kurzrock Razelle, Aggarwal Charu, Weipert Caroline, Kiedrowski Lesli, Riess Jonathan, Lenz Heinz-Josef, Gandara Dav |
| Molecular characterization-based multi-omics analyses in primary liver cancer using the Japanese version of the genome atlas. Journal of hepato-biliary-pancreatic sciences 2022 8 . Imamura Taisuke, Okamura Yukiyasu, Ohshima Keiichi, Uesaka Katsuhiko, Sugiura Teiichi, Yamamoto Yusuke, Ashida Ryo, Ohgi Katsuhisa, Nagashima Takeshi, Yamaguchi K |
| Clinical, Genomic, and Transcriptomic Data Profiling of Biliary Tract Cancer Reveals Subtype-Specific Immune Signatures. JCO precision oncology 2022 6 6 e2100510. Mody Kabir, Jain Prerna, El-Refai Sherif M, Azad Nilofer S, Zabransky Daniel J, Baretti Marina, Shroff Rachna T, Kelley R Katie, El-Khouiery Anthony B, Hockenberry Adam J, Lau Denise, Lesinski Gregory B, Yarchoan Ma |
| Cell-Free Tumor DNA Dominant Clone Allele Frequency Is Associated With Poor Outcomes in Advanced Biliary Cancers Treated With Platinum-Based Chemotherapy. JCO precision oncology 2022 Jun 6 e2100274. Uson Junior Pedro Luiz Serrano, Majeed Umair, Yin Jun, Botrus Gehan, Sonbol Mohamad Bassam, Ahn Daniel H, Starr Jason S, Jones Jeremy C, Babiker Hani, Inabinett Samantha R, Wylie Natasha, Boyle Ashton W R, Bekaii-Saab Tanios S, Gores Gregory J, Smoot Rory, Barrett Michael, Nagalo Bolni, Meurice Nathalie, Elliott Natalie, Petit Joachim, Zhou Yumei, Arora Mansi, Dumbauld Chelsae, Barro Oumar, Baker Alexander, Bogenberger James, Buetow Kenneth, Mansfield Aaron, Mody Kabir, Borad Mitesh |
| Mutation spectrum associated with metastasis of advanced cholangiocarcinoma. The Journal of international medical research 2022 Jun 50 (6): 3000605221102080. Song Hao, Huang Yao, Jiang Xiaoqi |
| Pan-tumor landscape of fibroblast growth factor receptor 1-4 genomic alterations. ESMO open 2022 12 7 (6): 100641. Murugesan K, Necchi A, Burn T C, Gjoerup O, Greenstein R, Krook M, López J A, Montesion M, Nimeiri H, Parikh A R, Roychowdhury S, Schwemmers S, Silverman I M, Vogel |
| Specific genomic alterations and prognostic analysis of perihilar cholangiocarcinoma and distal cholangiocarcinoma. Journal of gastrointestinal oncology 2021 Dec 12 (6): 2631-2642. Zheng Yuanwen, Qin Yejun, Gong Wei, Li Hongguang, Li Bin, Wang Yu, Chao Baoting, Zhao Shulei, Liu Luguang, Yao Shuzhan, Shi Junping, Shi Xiaoliang, Wang Kai, Xu Shife |
| Therapeutic targeting of ARID1A and PI3K/AKT pathway alterations in cholangiocarcinoma. PeerJ 2022 1 10 e12750. Tessiri Supharada, Techasen Anchalee, Kongpetch Sarinya, Namjan Achira, Loilome Watcharin, Chan-On Waraporn, Thanan Raynoo, Jusakul Apin |
| ARID1A Mutation from Targeted NGS Predicts Primary Resistance to Gemcitabine and Cisplatin Chemotherapy in Advanced Biliary Tract Cancer. Cancer research and treatment 2023 5 . Sung Hwan Lee, Jaekyung Cheon, Seoyoung Lee, Beodeul Kang, Chan Kim, Hyo Sup Shim, Young Nyun Park, Sanghoon Jung, Sung Hoon Choi, Hye Jin Choi, Choong-Kun Lee, Hong Jae Ch |
| Hepatic Sarcomatoid Carcinoma Is an Aggressive Hepatic Neoplasm Sharing Common Molecular Features With Its Conventional Carcinomatous Counterparts. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2023 2 36 (1): 100042. Yoshuantari Naomi, Jeng Yung-Ming, Liau Jau-Yu, Lee Chia-Hsiang, Tsai Jia-Hu |
| Immune checkpoint inhibitor-related molecular markers predict prognosis in extrahepatic cholangiocarcinoma. Cancer medicine 2023 10 . Bao Jin, Yuxin Wang, Baoluhe Zhang, Haifeng Xu, Xin Lu, Xinting Sang, Wenze Wang, Yilei Mao, Pengxiao Chen, Shun Wang, Zhirong Qian, Yingyi Wang, Shunda |
| Molecular profiling of biliary tract cancers reveals distinct genomic landscapes between circulating and tissue tumor DNA. Experimental hematology & oncology 2024 1 13 (1): 2. Clémence Astier, Carine Ngo, Léo Colmet-Daage, Virginie Marty, Olivia Bawa, Claudio Nicotra, Maud Ngo-Camus, Antoine Italiano, Christophe Massard, Jean-Yves Scoazec, Cristina Smolenschi, Michel Ducreux, Antoine Hollebecque, Sophie Postel-Vin |
| Genomic characterization and immunotherapy for microsatellite instability-high in cholangiocarcinoma. BMC medicine 2024 1 22 (1): 42. Xu Yang, Baofeng Lian, Nan Zhang, Junyu Long, Yiran Li, Jingnan Xue, Xiangqi Chen, Yunchao Wang, Yanyu Wang, Ziyu Xun, Mingjian Piao, Chenpei Zhu, Shanshan Wang, Huishan Sun, Zhijian Song, Leilei Lu, Xiaowei Dong, Aodi Wang, Wenjin Liu, Jie Pan, Xiaorong Hou, Mei Guan, Li Huo, Jie Shi, Haohai Zhang, Jinxue Zhou, Zhenhui Lu, Yilei Mao, Xinting Sang, Liqun Wu, Xiaobo Yang, Kai Wang, Haitao Zh |
- Page last reviewed:Feb 1, 2024
- Content source: